Revision history
MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults — 1 version recorded. Nothing here has been overwritten.
-
MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults